Identification of a specific autoantigen in opticospinal form of multiple sclerosis based on the HLA-DPB1 binding motif

基于 HLA-DPB1 结合基序鉴定多发性硬化症视脊髓形式的特异性自身抗原

基本信息

  • 批准号:
    12557060
  • 负责人:
  • 金额:
    $ 8.64万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

Multiple sclerosis (MS) is currently hypothesized to be mediated by autoreactive T cells against myelin antigens. In Japanese, MS frequently and selectively affects the optic nerve and spinal cord. We have previously reported that the opticospinal form of MS (OS-MS) has been shown to be distinct from the conventional form of MS (C-MS) clinically, immunologically and immunogenetically. Recently, oligodendrocytes have been demonstrated to have plural origins, showing marked differences in distribution depending on their origin. We assumed that the specific autoantigens which exist in the optic nerve and spinal cord may be associated with development of OS-MS lesions.To identify the autoantigens in OS-MS, we made use of an immunoscreening of a human spinal cord cDNA expression library with serum samples obtained from patients with OS-MS. cDNA expression library was prepared from human spinal cord and 5 X 10^5 to 10 X 10^5 phage plaques were immunoscreened with sera obtained from eight OS- … More MS patients. Eleven positive immunoreactive clones were identified by their reactivity to the sera, and their sequences were analyzed. Comparisons of the sequences showed that these clones represented cDNAs from 5 distinct genes (HSP105, Rabaptin-5, NSD1, KIAA1640, KIAA0640). We produced GST-Rabaptin-5 fusion protein and HSP105 protein and evaluated the titer of IgG anti-Rabaptin-5 and anti-HSP105 autoantibody in sera and CSF, using ELISA. We found IgG anti-Rabaptin-5 reactivities were not significantly elevated, however IgG anti-HSP105 reactivities in MS patients was significantly higher than those in normal controls (p = 0.0193). Anti-HSP105 reactivities were found in 3 % (2/66) of normal controls, while 14.5 % (10/69) of patients with MS were positive for anti-HSP105 antibodies. The difference in prevalence of autoantibodies was not statistically significant between OS-MS and C-MS. The HSP105 α-reactive T cell lines derived from CD4^+CD45RO^+ T cells were established from 3 of 9 MS patients but not normal controls. Our findings indicate HSP105 to be a novel candidate autoantigen in MS. In future, we are going to analyze the other candidate autoantigens (NSD1, KIAA1640, KIAA0610). Less
当前假设多发性硬化症(MS)是由自身反应性T细胞针对髓磷脂抗原介导的。在日语中,MS经常和有选择地影响视神经和脊髓。我们先前已经报道说,MS(OS-MS)的视脊髓形式已被证明与临床,免疫学和免疫生成的MS(C-MS)的常规形式不同。最近,已经证明少突胶质细胞具有复数起源,根据其起源而显示出明显的分布差异。我们假设在视神经和脊髓中存在的特定自身抗原可能与OS-MS病变的发展有关。为了鉴定OS-MS中的自身抗原,我们利用了人脊髓cDNA表达文库的免疫统计,并使用患有OS-MS患者获得的血清样品进行了血清样品。从人脊髓制备cDNA表达文库,并用从八名OS-…更多MS患者获得的血清免疫斑块5 x 10^5至10 x 10^5。通过对血清的反应性鉴定了11个阳性免疫反应性克隆,并分析了它们的序列。序列的比较表明,这些克隆代表来自5个不同基因的cDNA(HSP105,Rabaptin-5,NSD1,KIAA1640,KIAA0640)。我们使用ELISA在血清和CSF中生产了GST-Rabaptin-5融合蛋白和HSP105蛋白,并评估了IgG抗Rabaptin-5和抗HSP105自身抗体的滴度。我们发现IgG抗Rabaptin-5反激活率没有显着升高,但是MS患者的IgG抗HSP105反激活率显着高于正常对照组中的IgG抗HSP105反应率(P = 0.0193)。在3%(2/66)的正常对照中发现了抗HSP105反应率,而14.5%(10/69)的MS患者对抗HSP105抗体呈阳性。在OS-MS和C-MS之间,自身抗体的患病率差异在统计学上没有统计学意义。从9个MS患者中的3例中建立了源自CD4^+ CD45RO^+ T细胞的Hsp105α反应T细胞系,但不是正常对照。我们的发现表明HSP105是MS中的新型候选自动抗原。将来,我们将分析其他候选自动抗原(NSD1,KIAA1640,KIAA0610)。较少的

项目成果

期刊论文数量(132)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Osoegawa M, Matsumoto S, Ochi H, Ishiwata K, Nakamura-Uchiyama F, Nawa Y, Yamasaki K, Horiuchi I, Ohyagi Y, Kira J: "Localized myelitis caused by visceral larva migrans due to Ascaris suum masquerading as an isolated spinal cord tumor"J Neurol Neurosurg P
Osoekawa M、Matsumoto S、Ochi H、Ishiwata K、Nakamura-Uchiyama F、Nawa Y、Yamasaki K、Horiuchi I、Ohyagi Y、Kira J:“由于猪蛔虫伪装成孤立的脊髓,导致内脏幼虫移行症引起的局部脊髓炎
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kira J: "A novel feature disclosed in opticospinal multiple sclerosis in Asians"Intern Med. 39. 272 (2000)
Kira J:“亚洲人视脊髓多发性硬化症的一个新特征”Intern Med。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nakatsura T, Senju S, Ito M, Nishimura Y^*, Itoh K.^* (^*equal contribution): "Cellular and Humoral Immune Responses to A Human Pancreatic Cancer Antigen, CLP, Originally Defined by the SEREX Method"Eur. J. Immunol.. (in press).
Nakatsura T、Senju S、Ito M、Nishimura Y^*、Itoh K.^*(^*同等贡献):“对人类胰腺癌抗原 (CLP) 的细胞和体液免疫反应,最初由 SEREX 方法定义”Eur。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Horiuchi I, et al.: "Acute myelitis following asthma attacks with onset after puberty"J Neurol Neurosurg Psychiatry. 68. 665-8 (2000)
Horiuchi I 等人:“青春期后发作的哮喘发作后的急性脊髓炎”J Neurol Neurosurg Psychiatry。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamasaki K et al.: "Hyperprolactinemia in opticospinal multiple sclerosis"Intern Med. 39. 296-299 (2000)
Yamasaki K 等人:“视神经脊髓多发性硬化症中的高催乳素血症”Intern Med。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KIRA Jun-ichi其他文献

KIRA Jun-ichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KIRA Jun-ichi', 18)}}的其他基金

Developing a cell transplantation therapy for chronic multiple sclerosis by using Schwann cells induced from mesenchymal stem cells
利用间充质干细胞诱导的雪旺细胞开发治疗慢性多发性硬化症的细胞移植疗法
  • 批准号:
    25670423
  • 财政年份:
    2013
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Connexin astrocytopathy in the pathogenesis of demyelination in concentric sclerosis and multiple sclerosis
连接蛋白星形细胞病在同心硬化症和多发性硬化症脱髓鞘发病机制中的作用
  • 批准号:
    23659459
  • 财政年份:
    2011
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of molecular targeted therapy of multiple sclerosis on the basis of membrane protein microarray analysis and gene interactions
基于膜蛋白微阵列分析和基因相互作用开发多发性硬化症分子靶向治疗
  • 批准号:
    22390178
  • 财政年份:
    2010
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of IL-17 producing T cells in opticospinal multiple sclerosis
产生 IL-17 的 T 细胞在视脊髓多发性硬化症中的作用
  • 批准号:
    18390261
  • 财政年份:
    2006
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of an animal model of opticospinal form of multiple sclerosis using the HLA-DP5 transgenic mice.
使用 HLA-DP5 转基因小鼠开发视脊髓形式的多发性硬化症动物模型。
  • 批准号:
    14370209
  • 财政年份:
    2002
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
MOLECULAR AND PATHOLOGICAL ANALYSIS OF SPINAL CORD EOSINOPHILIC LESIONS IN ATOPIC MYELITIS
特应性脊髓炎脊髓嗜酸性病变的分子和病​​理学分析
  • 批准号:
    12470142
  • 财政年份:
    2000
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Induction of chronic inflammatory myelopathy in rats infected with recombinant HTLV-I
重组HTLV-I感染大鼠慢性炎症性脊髓病的诱导
  • 批准号:
    10557062
  • 财政年份:
    1998
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Establishment of a polyreactive T cell clone from Asian type multiple sclerosis patients and identification of the responsible antigens
亚洲型多发性硬化症患者多反应性 T 细胞克隆的建立及相关抗原的鉴定
  • 批准号:
    10470154
  • 财政年份:
    1998
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of T cell epitope in Asian type multiple sclerosis
亚洲型多发性硬化症T细胞表位分析
  • 批准号:
    08670712
  • 财政年份:
    1996
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Development of an animal model of opticospinal form of multiple sclerosis using the HLA-DP5 transgenic mice.
使用 HLA-DP5 转基因小鼠开发视脊髓形式的多发性硬化症动物模型。
  • 批准号:
    14370209
  • 财政年份:
    2002
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了